Binh Dinh, February 6, 2024 – Bidiphar, a prominent player in Vietnam’s pharmaceutical landscape, outlined its ambitious goals for 2024 at its annual employee conference. Aiming for a revenue of 2,000 billion VND (approximately 86 million USD) and a pre-tax profit of 320 billion VND (approximately 13.8 million USD), the company seeks to solidify its position as a leading force in the industry.
2023: A Year of Solid Performance and Social Responsibility
Looking back at 2023, BIDIPHAR reported an impressive 10% increase in revenue from manufactured goods, reaching 1,658 billion VND. This reflects the company’s commitment to innovation and quality, evidenced by its total profit before tax exceeding 320 billion VND, surpassing both planned and prior year figures by 7%.
BIDIPHAR’s commitment extends beyond financial success. The company actively promotes social responsibility, contributing nearly 2 billion VND to initiatives supporting disadvantaged communities. These included providing aid to remote areas, offering scholarships to underprivileged students, and constructing houses for families in need.
Charting a Course for Continued Growth in 2024
With renewed energy, BIDIPHAR sets its sights on achieving a remarkable 2,000 billion VND revenue target in 2024. Manufactured goods alone are expected to contribute 1,950 billion VND, demonstrating the company’s focus on internal production capabilities. To ensure the highest quality standards, BIDIPHAR is committed to completing the GMP-EU certification for its injectable and oral cancer drugs on schedule. This demonstrates the company’s dedication to patient safety and compliance with international regulations.
Embracing digitalization as a key driver of progress, BIDIPHAR plans to further invest in technological advancements. This includes streamlining internal processes, enhancing communication channels, and optimizing customer experiences. Such efforts will undoubtedly contribute to the company’s overall efficiency and competitiveness.
Cultural Values and Recognition Drive Excellence
BIDIPHAR fosters a strong corporate culture centered around “responsibility and sharing.” This philosophy emphasizes employee well-being, community engagement, and continuous improvement. Recognizing the dedication of its workforce, the company awarded a total of over 1 billion VND in bonuses to 13 outstanding teams and 37 exceptional individuals.
BIDIPHAR’s achievements haven’t gone unnoticed. The company secured a place among Vietnam’s Top 5 pharmaceutical companies and received the Prime Minister’s Emulation Flag for its exemplary performance in 2022. Additionally, Ms. Pham Thi Thanh Huong, BIDIPHAR’s General Director, was bestowed the Second-Class Labor Medal by the President of Vietnam, a testament to her leadership and contributions to the industry.
Looking Ahead with Optimism
BIDIPHAR’s unwavering commitment to innovation, quality, social responsibility, and employee well-being has paved the way for its remarkable success. With a clear vision, ambitious goals, and a dedicated workforce, the company is well-positioned to conquer the challenges of 2024 and solidify its position as a frontrunner in Vietnam’s pharmaceutical industry. As BIDIPHAR embarks on this exciting journey, one can only expect continued growth, impactful contributions, and further recognition for its dedication to excellence.
